St. Francis Cancer Center | St. Francis Cancer Center | Prolong SGHY-001 (Sanguinate)
st francis cancer center, cancer center greenville sc, cancer care greenville sc, aya cancer care, aya cancer care greenville sc
clinical-trial-template-default,single,single-clinical-trial,postid-1708,ajax_fade,page_not_loaded,,qode-child-theme-ver-1.0.0,qode-theme-ver-3.2,wpb-js-composer js-comp-ver-4.12,vc_responsive

Clinical Trials

Prolong SGHY-001 (Sanguinate)

An Open-Label Phase 1 Safety Study of SANGUINATE infusion in patients with acute severe anemia who are unable to receive red blood cell transfusion. >Read More

« Available Clinical Trials